These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8100817)

  • 21. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
    Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P-glycoprotein potentiates CYP3A4-mediated drug disappearance during Caco-2 intestinal secretory detoxification.
    Chan LM; Cooper AE; Dudley AL; Ford D; Hirst BH
    J Drug Target; 2004; 12(7):405-13. PubMed ID: 15621665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism.
    Bleasby K; Chauhan S; Brown CD
    Br J Pharmacol; 2000 Feb; 129(3):619-25. PubMed ID: 10711363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the transport of the organic cation [3H]MPP+ in human intestinal epithelial (Caco-2) cells.
    Martel F; Calhau C; Azevedo I
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):505-13. PubMed ID: 10832604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.
    Alsenz J; Steffen H; Alex R
    Pharm Res; 1998 Mar; 15(3):423-8. PubMed ID: 9563072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of forskolin with the P-glycoprotein multidrug transporter.
    Morris DI; Speicher LA; Ruoho AE; Tew KD; Seamon KB
    Biochemistry; 1991 Aug; 30(34):8371-9. PubMed ID: 1679346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of sparfloxacin from the human intestinal Caco-2 cell line is altered by P-glycoprotein inhibitors.
    Cormet-Boyaka E; Huneau JF; Mordrelle A; Boyaka PN; Carbon C; Rubinstein E; Tomé D
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2607-11. PubMed ID: 9756763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
    Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
    J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive interaction of cyclosporins with the Vinca alkaloid-binding site of P-glycoprotein in multidrug-resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1990 Sep; 265(27):16509-13. PubMed ID: 1975813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional expression of P-glycoproteins in secretory vesicles.
    Ruetz S; Gros P
    J Biol Chem; 1994 Apr; 269(16):12277-84. PubMed ID: 7909318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential transport properties of two mdr gene products are distinguished by progesterone.
    Yang CP; Cohen D; Greenberger LM; Hsu SI; Horwitz SB
    J Biol Chem; 1990 Jun; 265(18):10282-8. PubMed ID: 1972378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional expression of murine multidrug resistance in Xenopus laevis oocytes.
    Castillo G; Vera JC; Yang CP; Horwitz SB; Rosen OM
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4737-41. PubMed ID: 1693776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic and natural opiates interact with P-glycoprotein in multidrug-resistant cells.
    Callaghan R; Riordan JR
    J Biol Chem; 1993 Jul; 268(21):16059-64. PubMed ID: 8101846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of P-glycoprotein-mediated drug transport by alterations in lipid fluidity of rat liver canalicular membrane vesicles.
    Sinicrope FA; Dudeja PK; Bissonnette BM; Safa AR; Brasitus TA
    J Biol Chem; 1992 Dec; 267(35):24995-5002. PubMed ID: 1360981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutually co-operative interactions between modulators of P-glycoprotein.
    Shao YM; Ayesh S; Stein WD
    Biochim Biophys Acta; 1997 Feb; 1360(1):30-8. PubMed ID: 9061037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines.
    Muller C; Bailly JD; Goubin F; Laredo J; Jaffrézou JP; Bordier C; Laurent G
    Int J Cancer; 1994 Mar; 56(5):749-54. PubMed ID: 7906257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells.
    Burton PS; Conradi RA; Hilgers AR; Ho NF
    Biochem Biophys Res Commun; 1993 Feb; 190(3):760-6. PubMed ID: 8439326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles.
    Ushigome F; Koyabu N; Satoh S; Tsukimori K; Nakano H; Nakamura T; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
    Pharm Res; 2003 Jan; 20(1):38-44. PubMed ID: 12608534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The multidrug transporter: rapid modulation of efflux activity monitored in single cells by the morphologic effects of vinblastine and daunomycin.
    Konen PL; Currier SJ; Rutherford AV; Gottesman MM; Pastan I; Willingham MC
    J Histochem Cytochem; 1989 Jul; 37(7):1141-5. PubMed ID: 2567301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.